BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 25559399)

  • 1. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.
    Beuschlein F; Weigel J; Saeger W; Kroiss M; Wild V; Daffara F; Libé R; Ardito A; Al Ghuzlan A; Quinkler M; Oßwald A; Ronchi CL; de Krijger R; Feelders RA; Waldmann J; Willenberg HS; Deutschbein T; Stell A; Reincke M; Papotti M; Baudin E; Tissier F; Haak HR; Loli P; Terzolo M; Allolio B; Müller HH; Fassnacht M
    J Clin Endocrinol Metab; 2015 Mar; 100(3):841-9. PubMed ID: 25559399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
    Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of surgery in the management of recurrent adrenocortical carcinoma.
    Erdogan I; Deutschbein T; Jurowich C; Kroiss M; Ronchi C; Quinkler M; Waldmann J; Willenberg HS; Beuschlein F; Fottner C; Klose S; Heidemeier A; Brix D; Fenske W; Hahner S; Reibetanz J; Allolio B; Fassnacht M;
    J Clin Endocrinol Metab; 2013 Jan; 98(1):181-91. PubMed ID: 23150691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.
    Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M
    Eur Urol; 2014 Apr; 65(4):832-8. PubMed ID: 24268504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.
    Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M;
    Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma.
    Sbiera S; Sbiera I; Ruggiero C; Doghman-Bouguerra M; Korpershoek E; de Krijger RR; Ettaieb H; Haak H; Volante M; Papotti M; Reimondo G; Terzolo M; Luconi M; Nesi G; Mannelli M; Libé R; Ragazzon B; Assié G; Bertherat J; Altieri B; Fadda G; Rogowski-Lehmann N; Reincke M; Beuschlein F; Fassnacht M; Lalli E
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3491-3498. PubMed ID: 28911143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study.
    Zhang F; Zhang F; Liu Z; Wu K; Zhu Y; Lu Y
    Adv Ther; 2019 Oct; 36(10):2756-2768. PubMed ID: 31471770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study.
    Elhassan YS; Altieri B; Berhane S; Cosentini D; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL
    Eur J Endocrinol; 2021 Nov; 186(1):25-36. PubMed ID: 34709200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of adrenocortical carcinoma liver metastasis: is it justified?
    Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR
    Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
    Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease.
    Asare EA; Wang TS; Winchester DP; Mallin K; Kebebew E; Sturgeon C
    Surgery; 2014 Dec; 156(6):1378-85; discussion 1385-6. PubMed ID: 25456914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management and clinical prognosis of adrenocortical carcinoma.
    Dong D; Li H; Yan W; Ji Z; Mao Q
    Urol Int; 2012; 88(4):400-4. PubMed ID: 22487802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic role of SF1, IGF2, Ki67, p53, adiponectin, and leptin receptors in human adrenal cortical tumors.
    Babińska A; Pęksa R; Wiśniewski P; Świątkowska-Stodulska R; Sworczak K
    J Surg Oncol; 2017 Sep; 116(3):427-433. PubMed ID: 28672049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocortical cancer: mortality, hormone secretion, proliferation and urine steroids - experience from a single centre spanning three decades.
    Calissendorff J; Calissendorff F; Falhammar H
    BMC Endocr Disord; 2016 Mar; 16():15. PubMed ID: 26984275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study.
    Simon G; Pattou F; Mirallié E; Lifante JC; Nominé C; Arnault V; de Calan L; Caillard C; Carnaille B; Brunaud L; Laplace N; Caiazzo R; Blanchard C
    Surgery; 2017 Jan; 161(1):249-256. PubMed ID: 27855966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operative intervention for recurrent adrenocortical cancer.
    Dy BM; Wise KB; Richards ML; Young WF; Grant CS; Bible KC; Rosedahl J; Harmsen WS; Farley DR; Thompson GB
    Surgery; 2013 Dec; 154(6):1292-9; discussion 1299. PubMed ID: 24238048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas.
    Morimoto R; Satoh F; Murakami O; Suzuki T; Abe T; Tanemoto M; Abe M; Uruno A; Ishidoya S; Arai Y; Takahashi K; Sasano H; Ito S
    Endocr J; 2008 Mar; 55(1):49-55. PubMed ID: 18187873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy.
    Ronchi CL; Sbiera S; Kraus L; Wortmann S; Johanssen S; Adam P; Willenberg HS; Hahner S; Allolio B; Fassnacht M
    Endocr Relat Cancer; 2009 Sep; 16(3):907-18. PubMed ID: 19240185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma.
    Fassnacht M; Hahner S; Polat B; Koschker AC; Kenn W; Flentje M; Allolio B
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4501-4. PubMed ID: 16895957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma.
    Huynh KT; Lee DY; Lau BJ; Flaherty DC; Lee J; Goldfarb M
    J Am Coll Surg; 2016 Sep; 223(3):485-92. PubMed ID: 27238874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.